What is Heading?
Heading Health is dedicated to improving access to high-quality, affordable healthcare, particularly for mental health disorders. The company specializes in personalized treatment solutions for chronic and treatment-resistant conditions such as depression, anxiety, and PTSD. Heading leverages a comprehensive toolkit that includes teletherapy, telepsychiatry, and interventional treatments like Spravato, transcranial magnetic stimulation, and intramuscular ketamine, aiming to make healing more accessible.
How much funding has Heading raised?
Heading has raised a total of $6M across 2 funding rounds:
Series A
$4.5M
Stock/Share Issuance
$1.5M
Series A (2023): $4.5M with participation from JAM Fund and Gron Ventures
Stock/Share Issuance (2025): $1.5M led by BrainsWay
Key Investors in Heading
BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, utilizing its proprietary Deep Transcranial Magnetic Stimulation platform technology. They are known for their FDA-cleared indications for major depressive disorder, obsessive-compulsive disorder, and smoking addiction.
JAM Fund
JAM Fund is an organization dedicated to cultivating the next generation of cyclocross racers and ambassadors for the sport of cycling, offering grants and programs to support young athletes.
Gron Ventures
Grøn Ventures is an investment firm that supports businesses and brands with the potential to become market leaders for decades, focusing on identifying and backing innovative companies with significant growth potential.
What's next for Heading?
The recent major strategic investment suggests Heading is poised for significant scaling and expansion. This capital infusion will likely fuel further development of its teletherapy and interventional treatment platforms, potentially broadening its service offerings and geographic reach. The company's focus on addressing complex mental health challenges positions it for continued growth in a market with increasing demand for accessible and effective care solutions. Future endeavors may include strategic partnerships and further technological advancements to enhance patient outcomes.
See full Heading company page
